Drugs / Aminohippurate Sodium
Aminohippurate Sodium
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | AMINOHIPPURATE SODIUM | — | 1944-12-30 | fda.gov ↗ |
Trials 3 · a red edge is where a trial was stopped
194319441945194619471948194919501951195219531954195519561957195819591960196119621963196419651966196719681969197019711972197319741975197619771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05065372 | Jul 2022 → Mar 2027 expected | cardiovascular disorder, diabetic kidney disease, type 1 diabetes mellitus | Kalie Tommerdahl | Recruiting | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03584217 | Oct 2018 → Jun 2023 | diabetic kidney disease, obesity disorder, type 2 diabetes mellitus | University of Colorado, Denver | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01156220 | Jan → Jun 2012 | — | University Medical Center Hamburg-Eppendorf | Withdrawn | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | aminohippurate sodium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01156220 ↗ |
| Known as | Aminohippurate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03584217 ↗ |
| Known as | Product name: Aminohipppurate Sodium "PAH" | “Product name: Aminohipppurate Sodium "PAH"” NCT01156220 ↗ |
| Modality | Diagnostic / imaging agent | “Diagnostic aid/agent used to measure effective renal plasma flow (ERPF)” NCT03584217 ↗ |
| Route | Other | “Injection, 500 mg, single dose over 5 min” NCT01156220 ↗ |